Larvol Delta - aTyr-Pharma-Advances-Development-of-Lead-Therapeutic-Candidate-ATYR1923-with-Announcement-of-efzotimod-as-Nonproprietary-Name

Stalaris (efzofitimod) - aTyr Pharma, Kyorin

https://www.globenewswire.com/news-release/2022/01/13/2366404/0/en/aTyr-Pharma-Advances-Development-of-Lead-Therapeutic-Candidate-ATYR1923-with-Announcement-of-efzofitimod-as-Nonproprietary-Name.html

Jan 13, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next